[Question 5. Strategies in respiratory therapy].

Rev Mal Respir

Service de pneumologie, CHU Pasteur, 30, avenue Voie-Romaine, 06002 Nice, France.

Published: November 2005

Download full-text PDF

Source

Publication Analysis

Top Keywords

[question strategies
4
strategies respiratory
4
respiratory therapy]
4
[question
1
respiratory
1
therapy]
1

Similar Publications

Objectives: Chest wall infiltration in primary lung cancer affects the surgical and therapeutic strategies. This study evaluates the efficacy of the chest wall vessel involvement in subpleural lung cancer (CWVI) on ultra-high-resolution CT (UHR-CT) for detecting chest wall invasion.

Materials And Methods: A retrospective analysis of lung cancer cases with confirmed pleural and chest wall invasion was conducted from November 2019 to April 2022.

View Article and Find Full Text PDF

Lung carcinoma incidence and fatality rates remain among the highest on a global scale. The efficacy of targeted therapies and immunotherapies is commonly compromised by the emergence of drug resistance and other factors, resulting in a lack of durable therapeutic benefits. Ferroptosis, a distinct pattern of cell death marked by the buildup of iron-dependent lipid peroxides, has been shown to be a novel and potentially more effective treatment for lung carcinoma.

View Article and Find Full Text PDF

Food protein induced enterocolitis syndrome: French practices assessment in children.

Arch Pediatr

January 2025

Sorbonne Université, Paediatric Nutrition and Gastroenterology Department, APHP-Trousseau Hospital, 26 avenue du Dr Arnold Netter, 75012 Paris, France. Electronic address:

Background: Food protein-induced enterocolitis syndrome (FPIES) is a specific non IgE-mediated food allergy. The international consensus guidelines defined diagnosis criteria and management plan in 2017.

Objectives: To assess practices regarding FPIES in France and in French-speaking countries, according to those guidelines.

View Article and Find Full Text PDF

Health networking on cancer in the European Union: a 'green paper' by the EU Joint Action on Networks of Expertise (JANE).

ESMO Open

January 2025

Evaluative Epidemiology Unit, Department of Epidemiology and Data Science, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

Health networking is in principle a formidable instrument to address many challenges posed by cancer, one of the two most common and most lethal non-communicable chronic diseases. The European Union (EU)'s Beating Cancer Plan foresaw the addition of new health networks to the four already existing European Reference Networks on rare cancers: the Network of Comprehensive Cancer Centres and several networks of expertise (NoEs), which will be shortly deployed on items as complex and poor-prognosis cancers, palliative care, survivorship, personalised primary and secondary prevention, omic technologies, hi-tech medical resources, and cancers in adolescents and young adults. The community of experts of the EU Joint Action, due to build such NoEs, has drafted this 'green paper', incorporating 13 open questions, in an effort to foster discussion on some open questions about health networking on cancer in the EU.

View Article and Find Full Text PDF

There is a small, but growing, evidence base on obtaining the patient's perspective on frailty, which can help guide future research and clinical management strategies. This mini-review provides a brief summary of some qualitative studies on the patient's perspective on frailty with a focus on the study design and emerging findings to date. We reviewed seven studies in total, examining how they approached the research question and their main findings.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!